Advancing Healthcare with Sanofi
网页3 天之前 · September 10, 2024. Media Update: ERS: Dupixent data reinforce clinically meaningful benefit from pooled analysis of two COPD phase 3 studies. Read the Press Release. See all press releases. Explore Sanofi's global impact through our science, healthcare R&D, and partnerships. Committed to advancing global health with …
Sanofi Careers: Explore Job Opportunities
网页How Sanofians Drive Their Careers. Our people in Sanofi have the power to drive their own careers to explore more through moving functions, countries and exploring gigs prior to taking that next career step. Hear firsthand from three Sanofians - Deya , Sharya and Miren on exploring more in Sanofi. Our Recruitment Process.
Sanofi Investor Relations: Creating Trust and Value | Sanofi
网页To contact the Investor Relations team: 46 avenue de la Grande Armée. 75017 Paris FRANCE. investor.relations (at) sanofi.com. Contact us. Stay informed with Sanofi's investor relations for insights on our strategy, financial performance, and upcoming events.
Sanofi Vaccines: Protecting Lives at Every Stage | Sanofi
网页Vaccines. From providing protection against disease at every stage of life to protecting humanity against emerging epidemics, vaccines help create and maintain healthy communities that keep life moving forward. Hyderabad, India.
Sanofi stock chart
网页2 天之前 · Sanofi stock chart. Ticker table to check the latest price updates. Date & Time: 03 September 2024 13:04 (GMT+02:00) Share. Market. Last. High.
Our Company, pioneering pharmaceutical innovations | Sanofi
网页In an uncertain and fast-moving environment, we hold ourselves to the highest standards. Code of Conduct. Sanofi, a global healthcare pharmaceutical company, is dedicated to improving lives through discovering, developing and delivering medicines and vaccines.
Financial Reports and Publications - Sanofi
网页Annual Report on Form 20-F 2013. Download PDF. Find the latest Sanofi financial statements and reports, offering detailed insights into our fiscal performance and strategic financial planning.
Sanofi Pipeline: Discover Our R&D Projects
网页2024年7月25日 · With a strong focus on difficult-to-treat diseases and immunization, our R&D pipeline includes 78 clinical-stage projects, 33 of which are in phase 3 or have been submitted to regulatory authorities for approval. Some of these are new molecular entities while others are existing products with potential new indications, or different formulations.
Latest Sanofi Press Releases and News | Sanofi
网页2024年8月26日 · Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3. Read the Press Release.
Nirsevimab shows positive topline results in RSV Phase 2/3
网页June 28, 2021. Download PDF. Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial. Respiratory syncytial virus (RSV) is the leading cause of hospitalization in all infants 1,2. Nirsevimab is being investigated as a first-in-class single dose immunization to provide protection for all infants entering their first RSV season.